LianBio to Participate in Upcoming Investor Conferences
June 01 2023 - 4:15PM
LianBio (Nasdaq: LIAN), a biotechnology company dedicated to
bringing innovative medicines to patients in China and other major
Asian markets, today announced that members of the management team
will participate in the following upcoming investor conferences:
- Jefferies Global Healthcare Conference – June
7-9, 2023
- Fireside Chat – June 8 at 4:30 pm ET
- Goldman Sachs Annual Global Healthcare
Conference – June 12-15, 2023
- Fireside Chat – June 15 at 10:00 am PT
A live audio webcast of the events will be accessible from the
Investors section of LianBio’s website at
https://investors.lianbio.com/ with a replay available following
the live event.
About LianBio
LianBio is a cross-border biotechnology company on a mission to
bring transformative medicines to historically underserved patients
in China and other Asian markets. Through partnerships with highly
innovative biopharmaceutical companies around the world, LianBio is
advancing a diversified portfolio of clinically validated product
candidates with the potential to drive new standards of care across
cardiovascular, oncology, ophthalmology, and inflammatory disease
indications. LianBio is establishing an international
infrastructure to position the company as a partner of choice with
a platform to provide access to China and other Asian markets. For
more information, please visit www.lianbio.com.
For investor inquiries, please contact:
Elizabeth Anderson, VP Communications and Investor
Relations
E: elizabeth.anderson@lianbio.com
T: +1 646 655 8390
For media inquiries, please contact:
Josh Xu, Director of Communications
E: josh.xu@lianbio.com
T: +86 136 6140 8315
Katherine Smith, Evoke Canale
E: katherine.smith@evokegroup.com
T: +1 619 849 5378
LianBio (NASDAQ:LIAN)
Historical Stock Chart
From May 2024 to Jun 2024
LianBio (NASDAQ:LIAN)
Historical Stock Chart
From Jun 2023 to Jun 2024